Abstract
Objective To investigate the safety and clinical outcomes of robotic surgery for early-stage cervical cancer. Methods Retrospective analysis of patient with early-stage cervical cancer(IA1-IB1) who were treated with robotic radical hysterectomy in Department of Obstetrics and Gynecology, Xijing Hospital of air force medical university, from Mar. 2014 to May 2016. The postoperative pathological and therapeutic conditions, and disease-free survival(DFS) and overall survive(OS) time of 3 or 5 years were analyzed. Results 401 patients were followed up for 3 years. Among them, 14 cases died, OS was 96.5% in 3 years, 22 cases died of recurrence, and DFS was 94.6% in 3 years. Among them, 130 patients completed 5-year follow-up. And 8 of the 130 patients died, 5-year OS was 93.8%. A total of 9 patients died of recurrence, and the 5-year DFS was 93.1%. Conclusions Open surgery is undoubtedly the right choice, but it cannot completely deny the minimally invasive surgery, including robotic surgery. Further clinical trials are needed to evaluate its safety and clinical outcomes. Key words: Robotic surgery; Early-stage cervical cancer; Disease-free survival; Overall survival
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
